Drugs
-
Information about Medications Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
-
Safety Information about Medications for ADHD
FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
12/12/2011- FDA Drug Safety Podcast for Healthcare Professionals: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
12/2011 FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
11/1/2011FDA Drug Safety Podcast for Healthcare Professionals: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
11/1/2011Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad de medicamentos usados para el tratamiento del Trastorno de Déficit de Atención con Hiperactividad (ADHD por sus siglas en inglés) en niños y adultos jóvenes
11/2011Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
6/23/2009; updated 4/2011FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guides
2/21/2007Adderall and Adderall XR (amphetamines) Information Atomoxetine (marketed as Strattera) Information - Information for Healthcare Professionals: Cylert (pemoline) Tablets and Chewable Tablets
10/2005
-
-
-